Labcorp Holdings Inc. Shs Unsponsored Brazilian Depositary Receipt Repr 0.25 Sh (L1CA34) Price & Analysis

L1CA34 Stock Chart & Stats

R$493.00-R$1.40(-0.28%)

At close: Oct 30 4:00 PM EDT

Day’s Range: BRL 493.00 - BRL 495.50
52-Week Range: BRL 311.86 - BRL 497.28
Previous Close: BRL 494.40
Volume: N/A
Average Volume (3M): 0
Market Cap: BRL 159.44B
Enterprise Value: BRL 167.96B
Total Cash (Recent Filing): N/A
Total Debt (Recent Filing): N/A
Price to Earnings (P/E): 31202.5
Beta: -0.26
Next Earnings: Feb 11, 2027
EPS Estimate: N/A
Next Dividend Ex-Date: N/A
Dividend Yield: 0.52%

Labcorp Holdings Inc. Shs Unsponsored Brazilian Depositary Receipt Repr 0.25 Sh News

Labcorp price target raised to $355 from $306 at Deutsche Bank

Deutsche Bank raised the firm’s price target on Labcorp (LH) to $355 from $306 and keeps a Hold rating on the shares. Published first on TheFly – the ultimate source

2d agoLH N6B

Labcorp price target raised to $420 from $380 at UBS

UBS analyst Kevin Caliendo raised the firm’s price target on Labcorp (LH) to $420 from $380 and keeps a Buy rating on the shares. Published first on TheFly – the

2d agoLH N6B

Erin Wright Reiterates Buy on Labcorp, Raising Price Target to $388 on Strong Execution and Long-Term Earnings Visibility

Morgan Stanley analyst Erin Wright has reiterated their bullish stance on LH stock, giving a Buy rating today. Erin Wright has given his Buy rating due to a combination of

3d agoLH N6B

Labcorp price target raised to $388 from $338 at Morgan Stanley

Morgan Stanley raised the firm’s price target on Labcorp (LH) to $388 from $338 and keeps an Overweight rating on the shares. A “beat and raise” in Q3 reinforces confidence

3d agoLH N6B

Labcorp price target raised to $396 from $361 at Baird

Baird raised the firm’s price target on Labcorp (LH) to $396 from $361 and keeps an Outperform rating on the shares. The firm updated its model following Q3 results. Published

3d agoLH N6B

Labcorp price target raised to $380 from $330 at Barclays

Barclays raised the firm’s price target on Labcorp (LH) to $380 from $330 and keeps an Equal Weight rating on the shares. The firm updated the company’s model post the

3d agoLH N6B

Labcorp price target raised to $410 from $365 at Leerink

Leerink analyst Michael Cherny raised the firm’s price target on Labcorp (LH) to $410 from $365 and keeps an Outperform rating on the shares. Published first on TheFly – the

3d agoLH N6B

Early notable gainers among liquid option names on October 28th

Notable gainers among liquid option names this morning include Vertiv Holdings (VRT) $237.23 +28.67, LabCorp (LH) $359.35 +28.18, Fortive (FTV) $66.75 +5.13, GE Hlthcare Tech Inc (GEHC) $76.32 +5.21, and

3d agoLH FTV

Labcorp raises FY26 adjusted EPS view to $18.30-$18.70 from $18.10-$18.55

Consensus $18.35. Raises FY26 revenue view to $14.78B-$14.89B from $14.71B-$14.83B, consensus $14.75B. Backs FY26 free cash flow view $1.24B-$1.36B. The company said, “Labcorp (LH) is updating 2026 full year guidance

4d agoLH N6B

Labcorp reports Q3 adjusted EPS $4.78, consensus $4.64

Reports Q3 revenue $3.81B, consensus $3.76B. “Labcorp (LH) delivered another strong quarter with 7% revenue growth, continued margin expansion and 14.5% adjusted EPS growth, leading to a raise in our

4d agoLH N6B

Waters, Labcorp partner to expand access to cervical cancer screening

Labcorp (LH) and Waters (WAT) announced a partnership to expand access to the FDA-approved BD Onclarity HPV Assay through Labcorp’s nationwide laboratory network beginning in late 2026. Cervical cancer is

1w agoLH WAT

Jared Haase Reaffirms Buy on Labcorp, Citing Multi-Pillar Growth Strategy and Achievable Medium-Term Financial Targets

William Blair analyst Jared Haase has reiterated their bullish stance on LH stock, giving a Buy rating today. Jared Haase has given his Buy rating due to a combination of

1M agoLH N6B

Regulatory Resilience and Strategic Upside Drive Lisa Gill’s Overweight/Buy Rating on Labcorp

J.P. Morgan analyst Lisa Gill has maintained their bullish stance on LH stock, giving a Buy rating on August 10. Lisa Gill’s rating is based on Labcorp’s solid positioning within

2M agoLH N6B

Labcorp: Guidance Raised, Biopharma Momentum Strengthens, and Price Target Increased to $360 on Higher FY27 EBITDA Multiple

Bank of America Securities analyst Michael Ryskin reiterated a Buy rating on Labcorp Holdings yesterday and set a price target of $360.00. Michael Ryskin has given his Buy rating due

3M agoLH N6B

L1CA34 FAQ

What was Labcorp Holdings Inc. Shs Unsponsored Brazilian Depositary Receipt Repr 0.25 Sh’s price range in the past 12 months?

Labcorp Holdings Inc. Shs Unsponsored Brazilian Depositary Receipt Repr 0.25 Sh lowest stock price was R$311.86 and its highest was R$497.28 in the past 12 months.

What is Labcorp Holdings Inc. Shs Unsponsored Brazilian Depositary Receipt Repr 0.25 Sh’s market cap?

Labcorp Holdings Inc. Shs Unsponsored Brazilian Depositary Receipt Repr 0.25 Sh’s market cap is R$159.44B.

When is Labcorp Holdings Inc. Shs Unsponsored Brazilian Depositary Receipt Repr 0.25 Sh’s upcoming earnings report date?

The company’s upcoming earnings report date is not yet available.

How were Labcorp Holdings Inc. Shs Unsponsored Brazilian Depositary Receipt Repr 0.25 Sh’s earnings last quarter?

Labcorp Holdings Inc. Shs Unsponsored Brazilian Depositary Receipt Repr 0.25 Sh released its earnings results on Oct 28, 2026. The company reported R$0.004 earnings per share for the quarter.

Is Labcorp Holdings Inc. Shs Unsponsored Brazilian Depositary Receipt Repr 0.25 Sh overvalued?

Not enough analysts have published a price target to calculate whether the price is overvalued.

Does Labcorp Holdings Inc. Shs Unsponsored Brazilian Depositary Receipt Repr 0.25 Sh pay dividends?

Labcorp Holdings Inc. Shs Unsponsored Brazilian Depositary Receipt Repr 0.25 Sh does not currently pay dividends.

What is Labcorp Holdings Inc. Shs Unsponsored Brazilian Depositary Receipt Repr 0.25 Sh’s EPS estimate?

Labcorp Holdings Inc. Shs Unsponsored Brazilian Depositary Receipt Repr 0.25 Sh’s EPS estimate for its next earnings report is not yet available.

How many shares outstanding does Labcorp Holdings Inc. Shs Unsponsored Brazilian Depositary Receipt Repr 0.25 Sh have?

Labcorp Holdings Inc. Shs Unsponsored Brazilian Depositary Receipt Repr 0.25 Sh has 81,100,000 shares outstanding.

What happened to Labcorp Holdings Inc. Shs Unsponsored Brazilian Depositary Receipt Repr 0.25 Sh’s price movement after its last earnings report?

Labcorp Holdings Inc. Shs Unsponsored Brazilian Depositary Receipt Repr 0.25 Sh reported an EPS of R$0.004 in its last earnings report. Following the earnings report the stock price went up 8.865%.

Which hedge fund is a major shareholder of Labcorp Holdings Inc. Shs Unsponsored Brazilian Depositary Receipt Repr 0.25 Sh?

Currently, no hedge funds are holding shares in BR:L1CA34

What is the TipRanks Smart Score and how is it calculated?

Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

Labcorp Holdings Inc. Shs Unsponsored Brazilian Depositary Receipt Repr 0.25 Sh (L1CA34) Earnings & Revenues

Historic Earnings Reports

Technical Analysis

Overall Consensus

Indicator	Bullish	Neutral	Bearish
Overall Consensus	15	1	6
Technical Analysis	3	1	6
Moving Averages	12	0	0

Technical Analysis >

Similar Stocks

Stocks similar to BR:L1CA34
Company	Price & Change	Follow
BR:GEHC34GE Healthcare Technologies Inc Shs Unsponsored Brazilian Depositary Receipt Repr 0.125 Sh
BR:I1LM34Illumina, Inc. Unsponsored Brazilian Depositary Receipt Repr 0.2 Sh
BR:Q1UE34Quest Diagnostics Incorporated Shs Unsponsored Brazilian Depositary Receipt Repr 0.5 Sh
BR:R1MD34ResMed Inc. Shs Unsponsored Brazilian Depositary Receipt Repr 0.25 Sh
BR:S1TE34STERIS PLC Unsponsored Brazilian Depositary Receipt Repr 0.05 Sh

Compare BR:L1CA34 Stocks >

Popular Stocks

Popular Stocks
Company	Price & Change	Follow
NVDANvidia
AAPLApple
MSFTMicrosoft

Labcorp Holdings Inc. Shs Unsponsored Brazilian Depositary Receipt Repr 0.25 Sh stock analysis

Labcorp Holdings Inc. Shs Unsponsored Brazilian Depositary Receipt Repr 0.25 Sh (L1CA34) Price & Analysis

L1CA34 Stock Chart & Stats

Labcorp Holdings Inc. Shs Unsponsored Brazilian Depositary Receipt Repr 0.25 Sh News

Labcorp price target raised to $355 from $306 at Deutsche Bank

Labcorp price target raised to $420 from $380 at UBS

Erin Wright Reiterates Buy on Labcorp, Raising Price Target to $388 on Strong Execution and Long-Term Earnings Visibility

Labcorp price target raised to $388 from $338 at Morgan Stanley

Labcorp price target raised to $396 from $361 at Baird

Labcorp price target raised to $380 from $330 at Barclays

Labcorp price target raised to $410 from $365 at Leerink

Early notable gainers among liquid option names on October 28th

Labcorp raises FY26 adjusted EPS view to $18.30-$18.70 from $18.10-$18.55

Labcorp reports Q3 adjusted EPS $4.78, consensus $4.64

Waters, Labcorp partner to expand access to cervical cancer screening

Jared Haase Reaffirms Buy on Labcorp, Citing Multi-Pillar Growth Strategy and Achievable Medium-Term Financial Targets

Regulatory Resilience and Strategic Upside Drive Lisa Gill’s Overweight/Buy Rating on Labcorp

Labcorp: Guidance Raised, Biopharma Momentum Strengthens, and Price Target Increased to $360 on Higher FY27 EBITDA Multiple

L1CA34 FAQ

Labcorp Holdings Inc. Shs Unsponsored Brazilian Depositary Receipt Repr 0.25 Sh (L1CA34) Earnings & Revenues

Technical Analysis

Overall Consensus

Similar Stocks

Popular Stocks

Become an Expert with TipRanks Premium